71 related articles for article (PubMed ID: 26183044)
1. Computed tomography assessment of early response to neoadjuvant therapy in colon cancer.
Dam C; Lund-Rasmussen V; Pløen J; Jakobsen A; Rafaelsen SR
Dan Med J; 2015 Jul; 62(7):. PubMed ID: 26183044
[TBL] [Abstract][Full Text] [Related]
2. Neoadjuvant chemotherapy in locally advanced colon cancer. A phase II trial.
Jakobsen A; Andersen F; Fischer A; Jensen LH; Jørgensen JC; Larsen O; Lindebjerg J; Pløen J; Rafaelsen SR; Vilandt J
Acta Oncol; 2015 Nov; 54(10):1747-53. PubMed ID: 25920359
[TBL] [Abstract][Full Text] [Related]
3. Selection of colon cancer patients for neoadjuvant chemotherapy by preoperative CT scan.
Nørgaard A; Dam C; Jakobsen A; Pløen J; Lindebjerg J; Rafaelsen SR
Scand J Gastroenterol; 2014 Feb; 49(2):202-8. PubMed ID: 24279811
[TBL] [Abstract][Full Text] [Related]
4. [Multimodal therapy for colon cancer: state of the art].
Weber T; Link KH
Zentralbl Chir; 2011 Aug; 136(4):325-33. PubMed ID: 21863510
[TBL] [Abstract][Full Text] [Related]
5. Preliminary outcome of a treatment strategy based on perioperative chemotherapy and surgery in patients with locally advanced colon cancer.
Arredondo J; Pastor C; Baixauli J; Rodríguez J; González I; Vigil C; Chopitea A; Hernández-Lizoáin JL
Colorectal Dis; 2013 May; 15(5):552-7. PubMed ID: 23398577
[TBL] [Abstract][Full Text] [Related]
6. Multicenter randomized phase II clinical trial comparing neoadjuvant oxaliplatin, capecitabine, and preoperative radiotherapy with or without cetuximab followed by total mesorectal excision in patients with high-risk rectal cancer (EXPERT-C).
Dewdney A; Cunningham D; Tabernero J; Capdevila J; Glimelius B; Cervantes A; Tait D; Brown G; Wotherspoon A; Gonzalez de Castro D; Chua YJ; Wong R; Barbachano Y; Oates J; Chau I
J Clin Oncol; 2012 May; 30(14):1620-7. PubMed ID: 22473163
[TBL] [Abstract][Full Text] [Related]
7. Tumor-stroma ratio predicts recurrence in patients with colon cancer treated with neoadjuvant chemotherapy.
Hansen TF; Kjær-Frifeldt S; Lindebjerg J; Rafaelsen SR; Jensen LH; Jakobsen A; Sørensen FB
Acta Oncol; 2018 Apr; 57(4):528-533. PubMed ID: 28980848
[TBL] [Abstract][Full Text] [Related]
8. Panitumumab in combination with infusional oxaliplatin and oral capecitabine for conversion therapy in patients with colon cancer and advanced liver metastases. The MetaPan study.
Leone F; Artale S; Marino D; Cagnazzo C; Cascinu S; Pinto C; Fornarini G; Tampellini M; Di Fabio F; Sartore-Bianchi A; De Carlis L; Pugliese R; Capussotti L; Gioeni L; Siena S; Aglietta M
Cancer; 2013 Oct; 119(19):3429-35. PubMed ID: 23868516
[TBL] [Abstract][Full Text] [Related]
9. MRI for Local Staging of Colon Cancer: Can MRI Become the Optimal Staging Modality for Patients With Colon Cancer?
Nerad E; Lambregts DM; Kersten EL; Maas M; Bakers FC; van den Bosch HC; Grabsch HI; Beets-Tan RG; Lahaye MJ
Dis Colon Rectum; 2017 Apr; 60(4):385-392. PubMed ID: 28267005
[TBL] [Abstract][Full Text] [Related]
10. Oxaliplatin added to fluorouracil-based preoperative chemoradiotherapy and postoperative chemotherapy of locally advanced rectal cancer (the German CAO/ARO/AIO-04 study): final results of the multicentre, open-label, randomised, phase 3 trial.
Rödel C; Graeven U; Fietkau R; Hohenberger W; Hothorn T; Arnold D; Hofheinz RD; Ghadimi M; Wolff HA; Lang-Welzenbach M; Raab HR; Wittekind C; Ströbel P; Staib L; Wilhelm M; Grabenbauer GG; Hoffmanns H; Lindemann F; Schlenska-Lange A; Folprecht G; Sauer R; Liersch T;
Lancet Oncol; 2015 Aug; 16(8):979-89. PubMed ID: 26189067
[TBL] [Abstract][Full Text] [Related]
11. Accuracy of radiological staging in identifying high-risk colon cancer patients suitable for neoadjuvant chemotherapy: a multicentre experience.
Dighe S; Swift I; Magill L; Handley K; Gray R; Quirke P; Morton D; Seymour M; Warren B; Brown G
Colorectal Dis; 2012 Apr; 14(4):438-44. PubMed ID: 21689323
[TBL] [Abstract][Full Text] [Related]
12. Adapted Choi response criteria for prediction of clinical outcome in locally advanced gastric cancer patients following preoperative chemotherapy.
Liu K; Li G; Fan C; Zhou C; Li J
Acta Radiol; 2012 Mar; 53(2):127-34. PubMed ID: 22156007
[TBL] [Abstract][Full Text] [Related]
13. Neoadjuvant capecitabine and oxaliplatin followed by synchronous chemoradiation and total mesorectal excision in magnetic resonance imaging-defined poor-risk rectal cancer.
Chau I; Brown G; Cunningham D; Tait D; Wotherspoon A; Norman AR; Tebbutt N; Hill M; Ross PJ; Massey A; Oates J
J Clin Oncol; 2006 Feb; 24(4):668-74. PubMed ID: 16446339
[TBL] [Abstract][Full Text] [Related]
14. High-risk features in potentially resectable colon cancer: a prospective MDCT-pathology agreement study.
Santiago IA; Rodrigues ER; Germano AS; Costa AM; Manso RT; Gomes AP; Leichsenring CD; Geraldes VM
Abdom Radiol (NY); 2016 Oct; 41(10):1877-90. PubMed ID: 27315073
[TBL] [Abstract][Full Text] [Related]
15. Neoadjuvant capecitabine and oxaliplatin before chemoradiotherapy and total mesorectal excision in MRI-defined poor-risk rectal cancer: a phase 2 trial.
Chua YJ; Barbachano Y; Cunningham D; Oates JR; Brown G; Wotherspoon A; Tait D; Massey A; Tebbutt NC; Chau I
Lancet Oncol; 2010 Mar; 11(3):241-8. PubMed ID: 20106720
[TBL] [Abstract][Full Text] [Related]
16. Tumour size is the only predictive factor of distant recurrence after pathological complete response to neoadjuvant chemotherapy in patients with large operable or locally advanced breast cancers: a sub-study of EORTC 10994/BIG 1-00 phase III trial.
Fei F; Messina C; Slaets L; Chakiba C; Cameron D; Bogaerts J; Bonnefoi H
Eur J Cancer; 2015 Feb; 51(3):301-9. PubMed ID: 25578377
[TBL] [Abstract][Full Text] [Related]
17. Relationship of clinical and pathologic response to neoadjuvant chemotherapy and outcome of locally advanced breast cancer.
Gajdos C; Tartter PI; Estabrook A; Gistrak MA; Jaffer S; Bleiweiss IJ
J Surg Oncol; 2002 May; 80(1):4-11. PubMed ID: 11967899
[TBL] [Abstract][Full Text] [Related]
18. [A case of curatively resected sigmoid colon cancer after mFOLFOX6 plus panitumumab neoadjuvant chemotherapy].
Yoshikawa K; Kuwata H; Nakahata Y
Gan To Kagaku Ryoho; 2014 Mar; 41(3):399-401. PubMed ID: 24743293
[TBL] [Abstract][Full Text] [Related]
19. A prospective pilot study to assess neoadjuvant chemotherapy for unresectable peritoneal carcinomatosis from colorectal cancer.
Hompes D; Aalbers A; Boot H; van Velthuysen ML; Vogel W; Prevoo W; van Tinteren H; Verwaal V
Colorectal Dis; 2014 Aug; 16(8):O264-72. PubMed ID: 24433532
[TBL] [Abstract][Full Text] [Related]
20. Level III axillary lymph nodes involvement in node positive breast cancer received neoadjuvant chemotherapy.
Fan Z; Li J; Wang T; Xie Y; Fan T; Lin B; Ouyang T
Breast; 2013 Dec; 22(6):1161-5. PubMed ID: 24080493
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
